Catalyst
Slingshot members are tracking this event:
Phase 1/2 trial updated data of LentiGlobin for β-Thalassemia and Sickle Disease expected at ASH December 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BLUE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 05, 2016
Occurred Source:
https://ash.confex.com/ash/2016/webprogram/Paper95383.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1/2 Trial, Lentiglobin, Beta-thalassemia, Ash 2016
